<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Diagnostics on Korea Invest Insights</title><link>https://koreainvestinsights.com/tags/diagnostics/</link><description>Recent content in Diagnostics on Korea Invest Insights</description><generator>Hugo -- gohugo.io</generator><language>en</language><copyright>koreainvestinsights.com · @korea_invest_insights</copyright><lastBuildDate>Tue, 14 Jul 2026 00:13:49 +0900</lastBuildDate><atom:link href="https://koreainvestinsights.com/tags/diagnostics/feed.xml" rel="self" type="application/rss+xml"/><item><title>Korea Quality Re-Rating Watch 2026-07-13: Kolmar, APR &amp; Seegene</title><link>https://koreainvestinsights.com/post/kr-daily-wrap-2026-07-13/</link><pubDate>Mon, 13 Jul 2026 16:30:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/kr-daily-wrap-2026-07-13/</guid><description>&lt;h2 id="macro-dashboard"&gt;Macro Dashboard
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Indicator&lt;/th&gt;
 &lt;th&gt;Level&lt;/th&gt;
 &lt;th&gt;5-Day Δ&lt;/th&gt;
 &lt;th&gt;Signal&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSPI&lt;/td&gt;
 &lt;td&gt;6,806.9&lt;/td&gt;
 &lt;td&gt;−11.1%&lt;/td&gt;
 &lt;td&gt;Bear&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSDAQ&lt;/td&gt;
 &lt;td&gt;799.4&lt;/td&gt;
 &lt;td&gt;−3.8%&lt;/td&gt;
 &lt;td&gt;Bear&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;USD/KRW&lt;/td&gt;
 &lt;td&gt;1,493&lt;/td&gt;
 &lt;td&gt;−2.3% (KRW +)&lt;/td&gt;
 &lt;td&gt;Neutral&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;VIX&lt;/td&gt;
 &lt;td&gt;16.25&lt;/td&gt;
 &lt;td&gt;+4.4%&lt;/td&gt;
 &lt;td&gt;Calm&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;US 10Y&lt;/td&gt;
 &lt;td&gt;4.57%&lt;/td&gt;
 &lt;td&gt;+9bps&lt;/td&gt;
 &lt;td&gt;Slight rise&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Brent&lt;/td&gt;
 &lt;td&gt;$78.55&lt;/td&gt;
 &lt;td&gt;+0.7%&lt;/td&gt;
 &lt;td&gt;Stable&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;Regime: KR Bear / US Neutral.&lt;/strong&gt; KOSPI&amp;rsquo;s five-day drawdown of −11.1% dwarfs KOSDAQ&amp;rsquo;s −3.8%, a 7.3pp size-skew gap that points to concentrated large-cap pressure rather than a broad market collapse. Derivative flows confirm: the market program sold a net ₩1.77tn while ETF net creation absorbed ₩961bn — passive inflows partially cushioning active-side exits. Futures basis at +11.22 shows mild premium. Breadth reads 50% of stocks above both the 50MA and 200MA, which keeps the underlying stock-selection environment in neutral territory even as the headline index prints Bear.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="market-wrap"&gt;Market Wrap
&lt;/h2&gt;&lt;p&gt;Today was a flow-shock session, not a fundamental reset. KOSPI breached 6,800 intraday as foreign investors registered a net ₩2.45tn sell and institutions added ₩680bn of net supply — one of the heavier combined-flow days of recent months.&lt;/p&gt;
&lt;p&gt;Three forces drove the risk-off tone:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;1. Leverage ETF regulation noise.&lt;/strong&gt; Policy discussions around leveraged ETF products unsettled short-term positioning in high-beta, momentum-heavy names, with semiconductor megacaps bearing the brunt.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;2. SK Hynix (000660.KS) earnings estimate cuts.&lt;/strong&gt; Sell-side models trimmed long-term contract profit estimates for SK Hynix, triggering sympathy pressure across the memory supply chain. Samsung Electronics (005930.KS) closed at ₩254,500 with both foreign and institutional investors on the sell side.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;3. US CPI pre-positioning.&lt;/strong&gt; With the July 14 US CPI print on deck, global risk appetite was already thin. Korea&amp;rsquo;s structural beta to US macro sentiment amplified what would otherwise have been a contained adjustment.&lt;/p&gt;
&lt;p&gt;The countervailing data point: TSMC&amp;rsquo;s June revenue came in at +67.9% YoY, with 2Q beating consensus by 0.4%. That argues against a structural AI demand destruction thesis — today&amp;rsquo;s selloff reads as a positioning and regulatory uncertainty event, not a demand inflection. Breadth holding at 50% above key moving averages supports that read.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="todays-quality-re-rating-candidates"&gt;Today&amp;rsquo;s Quality Re-Rating Candidates
&lt;/h2&gt;
 &lt;blockquote&gt;
 &lt;p&gt;&lt;strong&gt;Data note:&lt;/strong&gt; Today&amp;rsquo;s daily operational screeners ran with errors and produced no fresh ranked output. The Meta Screener (dated 2026-07-13) uses today&amp;rsquo;s Kiwoom Market Surface for flow overlays, but the underlying Quality Compounder, Smart Money, Cycle Rerating, and PEAD signals are sourced from the 2026-07-07 screener run. All candidates below are a research queue — verify current price and flow data before drawing conclusions.&lt;/p&gt;

 &lt;/blockquote&gt;
&lt;p&gt;The editorial lens: good businesses where capital is entering and the market is beginning to re-price the story. Three layers checked — quality (durable business fundamentals), money flow (institutional/foreign footprint), and re-rating catalyst (earnings leverage being recognized in price).&lt;/p&gt;
&lt;h3 id="candidate-table"&gt;Candidate Table
&lt;/h3&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th style="text-align: right"&gt;Rank&lt;/th&gt;
 &lt;th&gt;Ticker&lt;/th&gt;
 &lt;th&gt;Name&lt;/th&gt;
 &lt;th style="text-align: right"&gt;Meta Score&lt;/th&gt;
 &lt;th&gt;Screeners&lt;/th&gt;
 &lt;th&gt;Key Metrics&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;1&lt;/td&gt;
 &lt;td&gt;161890.KS&lt;/td&gt;
 &lt;td&gt;Korea Kolmar&lt;/td&gt;
 &lt;td style="text-align: right"&gt;76.9&lt;/td&gt;
 &lt;td&gt;QC · SMQ · CR · SME (4)&lt;/td&gt;
 &lt;td&gt;ROE 14.7%, OP YoY +23.6%, Margin +0.9pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;2&lt;/td&gt;
 &lt;td&gt;278470.KS&lt;/td&gt;
 &lt;td&gt;APR&lt;/td&gt;
 &lt;td style="text-align: right"&gt;70.9&lt;/td&gt;
 &lt;td&gt;QC · SMQ · SME · PEAD (4)&lt;/td&gt;
 &lt;td&gt;ROE 65.0%, OP YoY +197.9%, Margin +7.0pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;3&lt;/td&gt;
 &lt;td&gt;096530.KQ&lt;/td&gt;
 &lt;td&gt;Seegene&lt;/td&gt;
 &lt;td style="text-align: right"&gt;69.4&lt;/td&gt;
 &lt;td&gt;QC · SMQ · CR · SME (4)&lt;/td&gt;
 &lt;td&gt;ROE 4.8%, OP YoY +309.7%, Margin +11.3pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;4&lt;/td&gt;
 &lt;td&gt;420770.KQ&lt;/td&gt;
 &lt;td&gt;Gigabis&lt;/td&gt;
 &lt;td style="text-align: right"&gt;62.6&lt;/td&gt;
 &lt;td&gt;QC · CR · Cons.Up (3)&lt;/td&gt;
 &lt;td&gt;ROE 7.3%, OP YoY +777.2%, Margin +29.9pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;5&lt;/td&gt;
 &lt;td&gt;089970.KQ&lt;/td&gt;
 &lt;td&gt;VM&lt;/td&gt;
 &lt;td style="text-align: right"&gt;57.7&lt;/td&gt;
 &lt;td&gt;QC · CR (2 + DART catalyst)&lt;/td&gt;
 &lt;td&gt;ROE 14.7%, OP YoY +386.9%, Margin +29.3pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;6&lt;/td&gt;
 &lt;td&gt;009150.KS&lt;/td&gt;
 &lt;td&gt;Samsung Electro-Mechanics&lt;/td&gt;
 &lt;td style="text-align: right"&gt;48.2&lt;/td&gt;
 &lt;td&gt;QC · CR (2 + IR catalyst)&lt;/td&gt;
 &lt;td&gt;ROE 7.4%, OP YoY +24.3%, Margin +0.9pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;7&lt;/td&gt;
 &lt;td&gt;271560.KS&lt;/td&gt;
 &lt;td&gt;Orion&lt;/td&gt;
 &lt;td style="text-align: right"&gt;44.4&lt;/td&gt;
 &lt;td&gt;QC · RS80 (2 + prelim earnings)&lt;/td&gt;
 &lt;td&gt;ROE 10.5%, OP YoY +2.7%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td style="text-align: right"&gt;8&lt;/td&gt;
 &lt;td&gt;000660.KS&lt;/td&gt;
 &lt;td&gt;SK Hynix&lt;/td&gt;
 &lt;td style="text-align: right"&gt;41.9&lt;/td&gt;
 &lt;td&gt;QC · CR (2, DART risk ×2)&lt;/td&gt;
 &lt;td&gt;ROE 35.6%, OP YoY +101.2%, Margin +13.1pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;em&gt;QC = Quality Compounder · SMQ = Smart Money Quality · CR = Cycle Rerating · SME = Smart Money Earnings · Cons.Up = Consensus Up Revision · RS80 = RS80 Not-Late Leadership&lt;/em&gt;&lt;/p&gt;
&lt;hr&gt;
&lt;h3 id="top-3-in-brief"&gt;Top 3 in Brief
&lt;/h3&gt;&lt;p&gt;&lt;strong&gt;Korea Kolmar (161890.KS) — Meta #1, score 76.9&lt;/strong&gt;
Korea Kolmar is a cosmetics OEM/ODM manufacturer with China-export exposure. It clears four screeners at once: Quality Compounder (ROE 14.7%), Smart Money Quality (5-day institutional/foreign net buying of +₩5.4bn absorbing ₩12.8bn of retail selling), Cycle Rerating (margin expansion +0.9pp), and Smart Money Earnings (OP YoY +23.6%, net income +34.2%). A confirmed IR event filed with DART on July 6 adds a near-term investor communication catalyst. Caution: short interest sits at 7.0% and program selling at −24.1% — technical overhang worth tracking.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;APR (278470.KS) — Meta #2, score 70.9&lt;/strong&gt;
APR operates K-beauty direct-to-consumer brands including Medicube. Growth metrics are outsized: ROE 65.0%, OP YoY +197.9%, revenue YoY +111.3%. It ranks #1 in the PEAD screener (post-earnings drift composite score +1.99, highest in this cohort) and tops both Smart Money Quality and Smart Money Earnings. The nuance: the 5-day net foreign/quality-institutional flow is −₩13.0bn with retail investors on the buy side — institutional momentum is the key variable to recheck against more recent data. The fundamental case remains intact; current flow direction needs verification.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Seegene (096530.KQ) — Meta #3, score 69.4&lt;/strong&gt;
Seegene is a PCR-based molecular diagnostics company emerging as an earnings inflection story. Four screeners: Quality Compounder, Smart Money Quality, Cycle Rerating (OP YoY +309.7% — the strongest operating income recovery in this cohort, margin expansion +11.3pp), and Smart Money Earnings. The 5-day flow pattern is clean: institutional/foreign net buying of +₩2.4bn against retail distribution of −₩5.2bn. Short interest at 14.2% is elevated and creates two-sided risk — potential squeeze catalyst if the earnings story firms, or a crowded-short overhang if it stalls. Program flow positive at +10.9%.&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;All figures sourced from the 2026-07-13 KR Meta Screener and 2026-07-13 KR Close Briefing. Underlying screener data dated 2026-07-07. This is market analysis, not investment advice.&lt;/em&gt;&lt;/p&gt;</description></item></channel></rss>